Get Premium Data for Cyber Monday: Up to 55% Off InvestingProCLAIM SALE

Tevogen Bio Holdings Inc (TVGN)

NASDAQ
Currency in USD
1.130
+0.080(+7.62%)
Closed
After Hours
1.1300.000(0.00%)
TVGN Scorecard
Full Analysis
Stock has taken a big hit over the last week
Fair Value
Day's Range
1.0701.160
52 wk Range
0.25621.090
Key Statistics
Edit
Prev. Close
1.05
Open
1.09
Day's Range
1.07-1.16
52 wk Range
0.256-21.09
Volume
1.02M
Average Volume (3m)
16.32M
1-Year Change
-89.76%
Book Value / Share
unlockUnlock
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
TVGN Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
4.200
Upside
+271.681%
Members' Sentiments
Bearish
Bullish
ProTips
Stock generally trades with high price volatility
Show more

Tevogen Bio Holdings Inc Company Profile

Tevogen Bio Holdings Inc. operates as a clinical-stage specialty immunotherapy company that develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment and prevention of chronic lingering symptoms of the disease (Long COVID), as well as COVID-19 in B cell immune suppressed acute COVID-19 patients without a B cell cancer indication, elderly and infirm acute COVID-19 patients, and acute COVID-19 in patients on T cell suppressing drugs, including solid organ transplant patients. It is also developing TVGN 601 for treating multiple sclerosis; TVGN 930 for the treatment of Epstein-Barr virus associated lymphomas; TVGN 920 for treating cervical cancer; and TVGN 960 for the treatment of mouth and throat cancer. The company was founded in 2020 and is headquartered in Warren, New Jersey.

Compare TVGN to Peers and Sector

Metrics to compare
TVGN
Peers
Sector
Relationship
P/E Ratio
−44.0x−3.2x−0.6x
PEG Ratio
−0.430.010.00
Price/Book
−15.2x0.2x2.6x
Price / LTM Sales
-2,179.0x3.2x
Upside (Analyst Target)
288.9%114.0%44.6%
Fair Value Upside
Unlock−6.3%7.3%Unlock

Analysts' Recommendations

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 4.200

(+271.68% Upside)

People Also Watch

0.264
TWG
-3.68%
0.801
IMG
+1.26%
1.040
GNPX
-3.70%
0.790
GRI
+21.57%

FAQ

What Is the Tevogen Bio Holdings (TVGN) Stock Price Today?

The Tevogen Bio Holdings stock price today is 1.13

What Stock Exchange Does Tevogen Bio Holdings Trade On?

Tevogen Bio Holdings is listed and trades on the NASDAQ stock exchange.

What Is the Stock Symbol for Tevogen Bio Holdings?

The stock symbol for Tevogen Bio Holdings is "TVGN."

What Is the Tevogen Bio Holdings Market Cap?

As of today, Tevogen Bio Holdings market cap is 197.81M.

What is Tevogen Bio Holdings Earnings Per Share?

The Tevogen Bio Holdings EPS is -0.036.

From a Technical Analysis Perspective, Is TVGN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.